Xylem (NYSE:XYL) Price Target Raised to $140.00

Key Points

• Xylem's price target has been raised by Mizuho from $125.00 to $140.00, indicating a potential downside of 1.02% from the current stock price.
• Several analysts have upgraded their ratings and price targets for Xylem, with UBS Group raising theirs to $168.00 and Stifel Nicolaus to $175.00, both maintaining a "buy" rating.
• Xylem reported earnings of $1.26 per share for the last quarter, beating expectations and showing a 6.1% revenue increase year-over-year.

Xylem (NYSE:XYL - Get Free Report) had its price objective hoisted by equities researchers at Mizuho from $125.00 to $140.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a "neutral" rating on the industrial products company's stock. Mizuho's target price would suggest a potential downside of 1.02% from the stock's current price.

A number of other research firms also recently issued reports on XYL. UBS Group lifted their price target on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research note on Tuesday, August 5th. Stifel Nicolaus lifted their price target on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Cowen restated a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. Citigroup restated a "buy" rating and issued a $152.00 target price (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. Finally, TD Cowen boosted their target price on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research note on Tuesday, August 26th. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $150.75.

Xylem Stock Down 0.2%

Shares of XYL traded down $0.35 during trading hours on Friday, hitting $141.45. The stock had a trading volume of 54,767 shares, compared to its average volume of 1,436,887. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The firm has a 50 day simple moving average of $138.01 and a 200-day simple moving average of $127.52. The firm has a market capitalization of $34.43 billion, a P/E ratio of 36.78, a price-to-earnings-growth ratio of 2.38 and a beta of 1.09. Xylem has a 1-year low of $100.47 and a 1-year high of $145.33.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period last year, the business posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts predict that Xylem will post 4.65 EPS for the current fiscal year.

Insider Activity

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Xylem by 2.4% during the second quarter. Vanguard Group Inc. now owns 29,697,829 shares of the industrial products company's stock valued at $3,841,711,000 after buying an additional 691,285 shares during the period. Geode Capital Management LLC boosted its position in Xylem by 2.3% during the second quarter. Geode Capital Management LLC now owns 6,141,231 shares of the industrial products company's stock valued at $791,029,000 after buying an additional 136,605 shares during the period. Amundi boosted its position in Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company's stock valued at $730,717,000 after buying an additional 830,337 shares during the period. Impax Asset Management Group plc boosted its position in Xylem by 13.7% during the second quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company's stock valued at $709,183,000 after buying an additional 663,191 shares during the period. Finally, Royal Bank of Canada boosted its position in Xylem by 7.9% during the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock valued at $506,985,000 after buying an additional 320,500 shares during the period. Institutional investors own 87.96% of the company's stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.